Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children

被引:174
作者
Dubinsky, Marla C. [1 ,2 ]
Kugathasan, Subra [3 ]
Mei, Ling [1 ,2 ]
Picornell, Yoana [1 ,2 ]
Nebel, Justin [3 ]
Wrobel, Iwona [4 ]
Quiros, Antonio [5 ]
Silber, Gary [6 ]
Wahbeh, Ghassan [7 ]
Katzir, Lirona [1 ,2 ]
Vasiliauskas, Eric [1 ,2 ]
Bahar, Ron [1 ,2 ]
Otley, Anthony [8 ]
Mack, David [9 ]
Evans, Jonathan [10 ]
Rosh, Joel [11 ]
Hemker, Maria Oliva [12 ]
Leleiko, Neal [13 ]
Crandall, Wallace [14 ]
Langton, Christine [15 ]
Landers, Carol [1 ,2 ]
Taylor, Kent D. [1 ,2 ]
Targan, Stephan R. [1 ,2 ]
Rotter, Jerome I. [1 ,2 ]
Markowitz, James [16 ]
Hyams, Jeffrey [15 ]
机构
[1] Cedars Sinai Med Ctr, IBD Ctr, Dept Pediat, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, IBD Ctr, Dept Internal Med, Los Angeles, CA 90048 USA
[3] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
[4] Alberta Childrens Prov Gen Hosp, Dept Pediat, Calgary, AB T2T 5C7, Canada
[5] UC Davis, Dept Pediat, Sacramento, CA USA
[6] Phoenix Childrens Hosp, Dept Pediat, Phoenix, AZ USA
[7] Seattle Childrens Hosp, Dept Pediat, Seattle, WA USA
[8] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada
[9] Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1H 8L1, Canada
[10] Nemours Childrens Clin, Dept Pediat, Jacksonville, FL USA
[11] Morristown Mem Hosp, Dept Pediat, Morristown, NJ USA
[12] Johns Hopkins Univ Hosp, Dept Pediat, Baltimore, MD 21287 USA
[13] Hasbro Childrens Hosp, Dept Pediat, Providence, RI USA
[14] Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA
[15] Connecticut Childrens Med Ctr, Dept Pediat, Hartford, CT USA
[16] Schneider Childrens Hosp, New Hyde Pk, NY USA
关键词
D O I
10.1016/j.cgh.2008.04.032
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The ability to identify children with CD who are at highest risk for rapid progression from uncomplicated to complicated phenotypes would be invaluable in guiding initial therapy. The aims of this study were to determine whether immune responses and/or CARD15 variants are associated with complicated disease phenotypes and predict disease progression. Methods: Sera were collected from 796 pediatric CD cases and tested for anti-Cbir1 (flagellin), and-outer membrane protein C, and-Saccharomyces cerevisiae, and perinuclear antineutrophil cytoplasmic antibody by using enzyme-linked immunosorbent assay. Genotyping (Taqman MGB) was performed for 3 CARD15 variants (single nucleotide polymorphisms 8, 12, and 13). Associations between immune responses (antibody sum and quartile sum score, CARD 15, and clinical phenotype were evaluated. Results: Thirty-two percent of patients developed at least I disease complication within a median of 32 months, and 18% underwent surgery. The frequency of internal penetrating, stricturing, and surgery significantly increased (P trend <.0001 for all 3 outcomes) with increasing antibody sum and quartile sum score. Nine percent of seropositive groups had internal penetrating/stricturing versus 2.9% in the seronegative group (P =.01). Twelve percent of seropositive groups underwent surgery versus 2% in the seronegative group (P =.0001). The highest antibody sum group (3) and quartile sum score group (4) demonstrated the most rapid disease progression (P <.0001). Increased hazard ratio was observed for antibody sum group 3 (7.8; confidence interval, 2.2-28.7), P <.002 and quartile sum score group 4 (11.0; confidence interval, 1.5-83.0, P <.02). Conclusions: The rate of complicated CD increases in children as the number and magnitude of immune reactivity increase. Disease progression is significantly faster in children expressing immune reactivity.
引用
收藏
页码:1105 / 1111
页数:7
相关论文
共 20 条
[1]   Efficient priming of PCR with short oligonucleotides conjugated to a minor groove binder [J].
Afonina, I ;
Zivarts, M ;
Kutyavin, I ;
Lukhtanov, E ;
Gamper, H ;
Meyer, RB .
NUCLEIC ACIDS RESEARCH, 1997, 25 (13) :2657-2660
[2]   Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients [J].
Amre, DK ;
Lu, SE ;
Costea, F ;
Seidman, EG .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (03) :645-652
[3]   Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype [J].
Arnott, IDR ;
Landers, CJ ;
Nimmo, EJ ;
Drummond, HE ;
Smith, BKR ;
Targan, SR ;
Satsangi, J .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2376-2384
[4]   Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease [J].
Corken Mackey, Ann ;
Green, Lanh ;
Liang, Li-ching ;
Dinndorf, Patricia ;
Avigan, Mark .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 44 (02) :265-267
[5]   Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease [J].
Dotan, Iris ;
Fishman, Sigal ;
Dgani, Yaara ;
Schwartz, Mikael ;
Karban, Amir ;
Lerner, Aaron ;
Weishauss, Oori ;
Spector, Larissa ;
Shtevi, Avi ;
Altstock, Rom T. ;
Dotan, Nir ;
Halpern, Zamir .
GASTROENTEROLOGY, 2006, 131 (02) :366-378
[6]   Serum immune responses predict rapid disease progression among children with Crohn's disease: Immune responses predict disease progression [J].
Dubinsky, MC ;
Lin, YC ;
Dutridge, D ;
Picornell, Y ;
Landers, CJ ;
Farrior, S ;
Wrobel, I ;
Quiros, A ;
Vasiliauskas, EA ;
Grill, B ;
Israel, D ;
Bahar, R ;
Christie, D ;
Wahbeh, G ;
Silber, G ;
Dallazadeh, S ;
Shah, P ;
Thomas, D ;
Kelts, D ;
Hershberg, RM ;
Elson, CO ;
Targan, SR ;
Taylor, KD ;
Rotter, JI ;
Yang, HY .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02) :360-367
[7]   Risk factors for initial surgery in pediatric patients with Crohn's disease [J].
Gupta, N ;
Cohen, SA ;
Bostrom, AG ;
Kirschner, BS ;
Baldassano, RN ;
Winter, HS ;
Ferry, GD ;
Smith, T ;
Abramson, O ;
Gold, BD ;
Heyman, MB .
GASTROENTEROLOGY, 2006, 130 (04) :1069-1077
[8]  
HOMMES D, 2005, GASTROENTEROLOGY, V129, P371
[9]   Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease [J].
Hugot, JP ;
Chamaillard, M ;
Zouali, H ;
Lesage, S ;
Cézard, JP ;
Belaiche, J ;
Almer, S ;
Tysk, C ;
O'Morain, CA ;
Gassull, M ;
Binder, V ;
Finkel, Y ;
Cortot, A ;
Modigliani, R ;
Laurent-Puig, P ;
Gower-Rousseau, C ;
Macry, J ;
Colombel, JF ;
Sahbatou, M ;
Thomas, G .
NATURE, 2001, 411 (6837) :599-603
[10]   Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children [J].
Hyams, Jeffrey ;
Crandall, Wallace ;
Kugathasan, Subra ;
Griffiths, Anne ;
Olson, Allan ;
Johanns, Jewel ;
Liu, Grace ;
Travers, Suzanne ;
Heuschkel, Robert ;
Markowitz, James ;
Cohen, Stanley ;
Winter, Harland ;
Veereman-Wauters, Gigi ;
Ferry, George ;
Baldassano, Robert .
GASTROENTEROLOGY, 2007, 132 (03) :863-873